Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect Comparisons
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect Comparisons ; volume:41 ; number:10 ; day:10 ; month:8 ; year:2024 ; pages:3832-3849 ; date:10.2024
Advances in therapy ; 41, Heft 10 (10.8.2024), 3832-3849, 10.2024
- Creator
-
Reinisch, Walter
Melmed, Gil Y.
Nakase, Hiroshi
Seidelin, Jakob
Ma, Christopher
Xuan, Si
Tran, Jacinda
Remple, Valencia
Wegrzyn, Lani
Levy, Gweneth
Sanchez Gonzalez, Yuri
Panaccione, Remo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-024-02912-y
- URN
-
urn:nbn:de:101:1-2411272135315.696037021913
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Reinisch, Walter
- Melmed, Gil Y.
- Nakase, Hiroshi
- Seidelin, Jakob
- Ma, Christopher
- Xuan, Si
- Tran, Jacinda
- Remple, Valencia
- Wegrzyn, Lani
- Levy, Gweneth
- Sanchez Gonzalez, Yuri
- Panaccione, Remo
- SpringerLink (Online service)
Other Objects (12)
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis
Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis
Comparisons of treatment satisfaction and health-related quality of life in patients with rheumatoid arthritis treated with tofacitinib and adalimumab
Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis
Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis
Comparisons of treatment satisfaction and health-related quality of life in patients with rheumatoid arthritis treated with tofacitinib and adalimumab
Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
Correction to: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis
Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis
Comparisons of treatment satisfaction and health-related quality of life in patients with rheumatoid arthritis treated with tofacitinib and adalimumab
Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database